RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS

被引:0
|
作者
KIRWAN, JR [1 ]
CURREY, HLF [1 ]
机构
[1] LONDON HOSP, LONDON E1 1BB, ENGLAND
来源
CLINICS IN RHEUMATIC DISEASES | 1983年 / 9卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:581 / 599
页数:19
相关论文
共 50 条
  • [21] Treatment Patterns of Disease-Modifying Anti-Rheumatic Drugs by Serostatus Among Patients with Rheumatoid Arthritis
    Jin, Yinzhu
    Liu, Jun
    Desai, Rishi
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3476 - 3479
  • [22] Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis
    Navarro-Millan, Iris
    Goyal, Parag
    Safford, Monika M.
    RHEUMATOLOGY, 2019, 58 (06) : 933 - 934
  • [23] Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs
    Pavelka, Karel
    Kavanaugh, Arthur F.
    Rubbert-Roth, Andrea
    Ferraccioli, Gianfranco
    RHEUMATOLOGY, 2012, 51 : V12 - V21
  • [24] Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
    Su, Yu-Jih
    Chen, Hui-Ming
    Chan, Tien-Ming
    Cheng, Tien-Tsai
    Yu, Shan-Fu
    Chen, Jia-Feng
    Lin, Chun-Yu
    Hsu, Chung-Yuan
    RMD OPEN, 2023, 9 (03):
  • [25] TIMING OF PNEUMOCOCCAL VACCINATIONS IN RELATION TO STARTING DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Costello, R. E.
    Humphreys, J.
    Winthrop, K.
    Dixon, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 961 - 962
  • [26] DISEASE-MODIFYING DRUGS IN RHEUMATOID-ARTHRITIS
    TRNAVSKI, K
    TERAPEVTICHESKII ARKHIV, 1984, 56 (05): : 19 - 21
  • [27] Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs
    Hanaoka, Hironari
    Kikuchi, Jun
    Hiramoto, Kazuoto
    Saito, Shuntaro
    Kondo, Yasushi
    Kaneko, Yuko
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1373 - 1378
  • [28] Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Garrood, T
    Scott, DL
    BIODRUGS, 2001, 15 (08) : 543 - 561
  • [29] Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
    Toby Garrood
    David L. Scott
    BioDrugs, 2001, 15 : 543 - 561
  • [30] Is cholecalciferol a potential disease-modifying anti-rheumatic drug for the management of rheumatoid arthritis?
    Bellan, M.
    Andreoli, L.
    Nerviani, A.
    Piantoni, S.
    Avanzi, G. C.
    Soddu, D.
    Hayden, E.
    Pirisi, M.
    Sainaghi, P. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 343 - 349